# Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network

> **NIH NIH U01** · INDIANA UNIVERSITY INDIANAPOLIS · 2024 · $200,000

## Abstract

Chronic pancreatitis (CP) is a progressive disease, often leading to loss of exocrine and endocrine
function and debilitating abdominal pain. It is unknown why some individuals progress and
develop complications, including pancreatogenic diabetes (T3cDM) and/or pancreas cancer
(PDAC). In the Consortium for the study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer
(CPDPC), initially formed in 2015, investigators have proposed and initiated several well-powered
studies of risk factors, environmental influences, and proof-of-concept studies to move the field
forward, particularly those factors that increase the risk of T3cDM and PDAC. In the second cycle
of the CPDPC, this administrative supplement will allow for ongoing recruitment and retention of
subjects in two of the CPDPC’s high-priority longitudinal studies, namely PROCEED and
INSPPIRE 2, as well as DETECT, designed to better define and characterize T3cDM.

## Key facts

- **NIH application ID:** 11143510
- **Project number:** 3U01DK108323-10S1
- **Recipient organization:** INDIANA UNIVERSITY INDIANAPOLIS
- **Principal Investigator:** Evan L Fogel
- **Activity code:** U01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $200,000
- **Award type:** 3
- **Project period:** 2015-09-28 → 2025-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11143510

## Citation

> US National Institutes of Health, RePORTER application 11143510, Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network (3U01DK108323-10S1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11143510. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
